Sign In
Buy ASRT
$23.47
+0.0200 (+0.0853%)
At Close: Jun 03, 2026
Assertio Provides Response to Letter from Short-seller
07:30am, Monday, 11'th Nov 2024
Claims about Rolvedon and Assertio's Accounting Practices are False and Baseless Short-seller's Press Release is Another Improper Attempt to Enrich Himself at Assertio's Expense Company Considering Ta
NEW YORK--(BUSINESS WIRE)--The Buxton Helmsley Group, Inc. (together with certain of its affiliates, “BHG” or “we”), a New York City-based investment fund manager that has now inverted its lon
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
08:00am, Friday, 11'th Oct 2024
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities o
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Friday, 04'th Oct 2024
LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities o
Assertio Holdings: Management Change Could Improve Comeback Chances
04:18pm, Wednesday, 11'th Sep 2024
After losing exclusivity with its prior flagship drug, pharma firm Assertio Holdings (ASRT) is angling for a comeback with a new flagship drug product. However, Assertio's latest fiscal results were m
Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
04:05pm, Tuesday, 03'rd Sep 2024
LAKE FOREST, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities
Assertio Holdings, Inc. (ASRT) Q2 2024 Earnings Call Transcript
09:45pm, Wednesday, 07'th Aug 2024
Assertio Holdings, Inc. (NASDAQ:ASRT ) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Matthew Kreps - Darrow Associates, IR Brendan O'Grady - Chief Executive Officer A
Assertio (ASRT) Reports Q2 Loss, Tops Revenue Estimates
06:46pm, Wednesday, 07'th Aug 2024
Assertio (ASRT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.13 per share a year ago.
Assertio Reports Second Quarter 2024 Financial Results
04:01pm, Wednesday, 07'th Aug 2024
Second Quarter Total Net Product Sales of $30.7 Million Rolvedon Growth Continues, with $15.1 million in Net Product Sales $7.4 Million in Cash Flow from Operations, Cash and Short-Term Investments In
Earnings Preview: Assertio (ASRT) Q2 Earnings Expected to Decline
11:06am, Wednesday, 31'st Jul 2024
Assertio (ASRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
04:05pm, Wednesday, 24'th Jul 2024
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities o
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04:30pm, Tuesday, 09'th Jul 2024
LAKE FOREST, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities o
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Assertio Holdings, Inc. (NASDAQ:
Assertio: An Extremely Asymmetric Bet Skewed To The Upside
09:51am, Thursday, 27'th Jun 2024
Assertio Holdings, Inc. shares present a significant upside potential due to ongoing turnaround efforts and proven success in monetizing underappreciated pharma assets. The merger with Spectrum Pharma
3 Penny Stocks With 458% Average Upside According to Wall Street Analysts
10:21am, Monday, 24'th Jun 2024
Investors might be intrigued by penny stocks because they are so cheap to own. By investing $100 into a stock that trades for $0.50, you can own 200 shares of a company in your portfolio.
